Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04601402
Title GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genome & Company

head and neck squamous cell carcinoma

transitional cell carcinoma

lung non-small cell carcinoma

Advanced Solid Tumor


Avelumab + GEN-001

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Yale Cancer Center Not yet recruiting New Haven Connecticut 06510 United States Details
Emory University Winship Cancer Institute Not yet recruiting Atlanta Georgia 30322 United States Details
Oregon Health & Science University Recruiting Portland Oregon 97239 United States Details
*Shaded cells indicate that there was no data available from for the field